Skip to main content
Caplight Logo









Akazi Capital

Akazi Capital

Overview

Akazi Capital is a crowd-powered impact fund that invests in female entrepreneurs in Sub-Saharan Africa.

Portfolio Companies

2

Investments

Akazi Capital investments
CompanyDateStageLead
HealthtrackaDec 2021Pre SeedCo-investor
Be Girl-SAFECo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Akazi Capital based?

Akazi Capital is headquartered in Kigali, Rwanda.

When was Akazi Capital founded?

Founding year information for Akazi Capital is not publicly available.

How many portfolio companies does Akazi Capital have?

Akazi Capital has 2 portfolio companies in Caplight's dataset.

What are some companies in Akazi Capital's portfolio?

Portfolio companies visible on Caplight include Healthtracka, Be Girl.

What was Akazi Capital's most recent investment shown here?

Akazi Capital's most recent investment in this portfolio sample was in Healthtracka in 2021.

What sectors does Akazi Capital focus on?

Akazi Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software.

What company stages does Akazi Capital focus on?

Akazi Capital typically invests at the Early stage.

Firmographic Details

HeadquartersKigali
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?